BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25990212)

  • 1. Cyclin-dependent kinase 11(p110) (CDK11(p110)) is crucial for human breast cancer cell proliferation and growth.
    Zhou Y; Han C; Li D; Yu Z; Li F; Li F; An Q; Bai H; Zhang X; Duan Z; Kan Q
    Sci Rep; 2015 May; 5():10433. PubMed ID: 25990212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK11
    Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q
    Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of CDK11(p58) in human breast cancer growth and angiogenesis.
    Chi Y; Huang S; Peng H; Liu M; Zhao J; Shao Z; Wu J
    BMC Cancer; 2015 Oct; 15():701. PubMed ID: 26470709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel.
    Liu X; Gao Y; Shen J; Yang W; Choy E; Mankin H; Hornicek FJ; Duan Z
    Mol Cancer Ther; 2016 Jul; 15(7):1691-701. PubMed ID: 27207777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells.
    Jia B; Choy E; Cote G; Harmon D; Ye S; Kan Q; Mankin H; Hornicek F; Duan Z
    Cancer Lett; 2014 Jan; 342(1):104-12. PubMed ID: 24007862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cyclin-dependent kinase 11 interacts with 14-3-3 proteins.
    Feng Y; Qi W; Martinez J; Nelson MA
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1503-9. PubMed ID: 15883043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection.
    Loyer P; Trembley JH; Grenet JA; Busson A; Corlu A; Zhao W; Kocak M; Kidd VJ; Lahti JM
    J Biol Chem; 2008 Mar; 283(12):7721-32. PubMed ID: 18216018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The siRNA-mediated silencing of Bmi-1 promotes apoptosis and inhibits invasion of MCF-7 breast cancer cells].
    Deng X; Wu X; Weng H; Song F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1036-40. PubMed ID: 27412932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of CBFβ by CDK11
    Feng Y; Liao Y; Zhang J; Shen J; Shao Z; Hornicek F; Duan Z
    Cell Commun Signal; 2019 Oct; 17(1):125. PubMed ID: 31610798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent kinase 11(p110) activity in the absence of CK2.
    Sachs NA; Vaillancourt RR
    Biochim Biophys Acta; 2003 Dec; 1624(1-3):98-108. PubMed ID: 14642819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer.
    Zhou Y; Shen JK; Hornicek FJ; Kan Q; Duan Z
    Oncotarget; 2016 Jun; 7(26):40846-40859. PubMed ID: 27049727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.
    Zuo X; Qin Y; Zhang X; Ning Q; Shao S; Luo M; Yuan N; Huang S; Zhao X
    Oncol Rep; 2014 May; 31(5):2358-64. PubMed ID: 24676336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roquin1 inhibits the proliferation of breast cancer cells by inducing G1/S cell cycle arrest via selectively destabilizing the mRNAs of cell cycle-promoting genes.
    Lu W; Zhou M; Wang B; Liu X; Li B
    J Exp Clin Cancer Res; 2020 Nov; 39(1):255. PubMed ID: 33228782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell development.
    Li T; Inoue A; Lahti JM; Kidd VJ
    Mol Cell Biol; 2004 Apr; 24(8):3188-97. PubMed ID: 15060143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110).
    Choi HH; Choi HK; Jung SY; Hyle J; Kim BJ; Yoon K; Cho EJ; Youn HD; Lahti JM; Qin J; Kim ST
    Oncogene; 2014 Jan; 33(1):108-15. PubMed ID: 23178491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
    Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer.
    Song W; Li W; Li L; Zhang S; Yan X; Wen X; Zhang X; Tian H; Li A; Hu JF; Cui J
    Oncotarget; 2015 Sep; 6(27):23764-75. PubMed ID: 26156017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation.
    Duan Z; Zhang J; Choy E; Harmon D; Liu X; Nielsen P; Mankin H; Gray NS; Hornicek FJ
    Clin Cancer Res; 2012 Sep; 18(17):4580-8. PubMed ID: 22791884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.